Trevi Therapeutics, Inc.
12.61USD
-0.3300 (-2.55%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on TRVI.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.13▼ | -$0.13 | 0 | 1 |
| Next quarter | -$0.14▼ | -$0.14 | 1 | 2 |
| Current year | -$0.48▼ | -$0.46 | 1 | 7 |
| Next year | -$0.58▼ | -$0.56 | 1 | 5 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.11 | -$0.11 | -0.00 (-0.9%) |
| 2026-03-31 | -$0.07 | -$0.09 | -0.02 (-23.3%) |
| 2025-12-31 | -$0.1 | -$0.06 | +0.04 (+37.2%) |
| 2025-09-30 | -$0.1 | -$0.08 | +0.02 (+19.1%) |
86 ratings from 18 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Jones Trading | Maintained | Buy | $24 $28 | Aug 14, 2026 |
| Oppenheimer | Maintained | Outperform | $24 $25 | Aug 7, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $25 $30 | Aug 7, 2026 |
| BMO Capital | Initiated | Outperform | $36 | Jul 21, 2026 |
| B. Riley Securities | Maintained | Buy | $21 $31 | Jul 20, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $21 $24 | Jul 20, 2026 |
| Needham | Reiterated | Buy | $23 | May 20, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $21 | May 6, 2026 |
| Needham | Maintained | Buy | $24 $23 | May 6, 2026 |
| D. Boral Capital | Maintained | Buy | $19 | Apr 17, 2026 |
| Jones Trading | Maintained | Buy | $25 $24 | Mar 19, 2026 |
| Morgan Stanley | Maintained | Overweight | $19 $18 | Mar 18, 2026 |
| D. Boral Capital | Maintained | Buy | $19 | Mar 18, 2026 |
| Needham | Maintained | Buy | $22 $24 | Mar 18, 2026 |
| D. Boral Capital | Maintained | Buy | $19 | Mar 9, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $21 | Mar 9, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $21 | Jan 9, 2026 |
| D. Boral Capital | Maintained | Buy | $19 | Jan 8, 2026 |
| Stifel | Maintained | Buy | $15 $18 | Dec 19, 2025 |
| Leerink Partners | Maintained | Outperform | $13 $16 | Nov 20, 2025 |
| D. Boral Capital | Maintained | Buy | $19 | Nov 14, 2025 |
| Oppenheimer | Maintained | Outperform | $23 $24 | Nov 14, 2025 |
| Morgan Stanley | Maintained | Overweight | $18 $19 | Nov 14, 2025 |
| Clear Street | Maintained | Buy | $11 $21 | Nov 14, 2025 |
| Morgan Stanley | Initiated | Overweight | $18 | Aug 21, 2025 |
31 filings from 15 insiders · 1 buy / 1 sell over 6m
Officers and directors of TRVI, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Heffernan Michael ThomasDirector | ExerciseStock Option (right to buy) | 21.1k | — | — | Sep 15, 2026 |
| Heffernan Michael ThomasDirector | ExerciseStock Option (right to buy) | 18.4k | — | — | Sep 15, 2026 |
| Heffernan Michael ThomasDirector | Sell | 100 | $15.88 | $2k | Sep 15, 2026 |
| Heffernan Michael ThomasDirector | Sell | 21.0k | $15.09 | $316k | Sep 15, 2026 |
| Heffernan Michael ThomasDirector | Exercise | 21.1k | $3.33 | $70k | Sep 15, 2026 |
| Heffernan Michael ThomasDirector | Sell | 100 | $15.88 | $2k | Sep 15, 2026 |
| Heffernan Michael ThomasDirector | Sell | 18.3k | $15.09 | $276k | Sep 15, 2026 |
| Heffernan Michael ThomasDirector | Exercise | 18.4k | $3.04 | $56k | Sep 15, 2026 |
| GALLETTA CHRISTOPHEROfficer | Exercise | 4.2k | $0.51 | $2k | Dec 2, 2025 |
| BASKETT FORESTBeneficial Owner of more than 10% of a Class of Security | Exerciseindirect | 1.85M | $1.37 | $2.54M | Apr 17, 2025 |
| WALKER PAUL EDWARDBeneficial Owner of more than 10% of a Class of Security | Exerciseindirect | 1.85M | $1.37 | $2.54M | Apr 17, 2025 |
| FLORENCE ANTHONY A JRBeneficial Owner of more than 10% of a Class of Security | Exerciseindirect | 1.85M | $1.37 | $2.54M | Apr 17, 2025 |
| BEHBAHANI ALIBeneficial Owner of more than 10% of a Class of Security | Exerciseindirect | 1.85M | $1.37 | $2.54M | Apr 17, 2025 |
| MAKHZOUMI MOHAMADBeneficial Owner of more than 10% of a Class of Security | Exerciseindirect | 1.85M | $1.37 | $2.54M | Apr 17, 2025 |
| NEW ENTERPRISE ASSOCIATES 16, L.P.Beneficial Owner of more than 10% of a Class of Security | Exerciseindirect | 1.85M | $1.37 | $2.54M | Apr 17, 2025 |
| CHANG CARMENBeneficial Owner of more than 10% of a Class of Security | Exerciseindirect | 1.85M | $1.37 | $2.54M | Apr 17, 2025 |
| SANDELL SCOTT DBeneficial Owner of more than 10% of a Class of Security | Exerciseindirect | 1.85M | $1.37 | $2.54M | Apr 17, 2025 |
| SCIASCIA THOMAS ROfficer | Sell | 2.6k | $6.60 | $17k | Mar 25, 2025 |
| SCIASCIA THOMAS ROfficer | Exercise | 2.6k | $1.43 | $4k | Mar 25, 2025 |
| GOOD JENNIFER LChief Executive Officer | Sell | 5.3k | $6.58 | $35k | Mar 21, 2025 |
No analyst notes on TRVI yet.
Members whose judged calls on TRVI have played out most reliably.
No settled calls on TRVI yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
11 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 9 | 0 | 0 | 0 | Buy1.82 |
| 1 mo ago | 2 | 9 | 0 | 0 | 0 | Buy1.82 |
| 2 mo ago | 2 | 9 | 0 | 0 | 0 | Buy1.82 |
| 3 mo ago | 2 | 9 | 0 | 0 | 0 | Buy1.82 |